Efficacy of lapatinib monotherapy on occult breast cancer

Efficacy of lapatinib monotherapy on occult breast cancer

5
(618)
Write Review
More
$ 10.99
Add to Cart
In stock
Description

Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches. - Abstract - Europe PMC

Eiichiro NOGUCHI, Tokyo Women's Medical University, Tokyo, Department of Surgery II

20745 PDFs Review articles in ERYTHEMA

Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Disease Study Group of Japan and the Japanese Study Group of the Standard Antiviral

Immunotherapy in combination with neoadjuvant anthracycline‑free chemotherapy for triple‑negative early breast cancer: A case report

PDF) Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

Breast cancer - The Lancet

Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)

PDF) Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

PDF) Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway

IJMS, Free Full-Text

Eiichiro NOGUCHI, Tokyo Women's Medical University, Tokyo, Department of Surgery II